The Latest Breaking News on Pharma

Walgreens Boots Alliance (WBA) is attempting to raise capital and regain market share. Given this scenario, should investors buy, sell, or hold the stock? Let’s look at its financial metrics to gauge its prospects….

The biotech industry is ascending with growing R&D initiatives, an upsurge in personalized medicine, and enhanced drug formulations, coupled with the incorporation of technological advancements. So, it seems wise to invest in discounted biotech stocks Vertex Pharmaceuticals (VRTX), Jazz Pharmaceuticals (JAZZ), and Alkermes (ALKS) this month. Keep reading….

Thanks to the company’s solid first-quarter performance and growing pharmaceutical demand, Johnson & Johnson’s (JNJ) long-term prospects look bright. However, could the company ensure stability for investors amid the current market volatility? Keep reading….

Police are still investigating the lab’s origins

Henrietta Lacks’ unique ‘Hela’ cells played a crucial role in the development of Covid-19 vaccines and treatments for HIV, leukemia and cancer

The National Institutes of Health is starting some studies to test possible treatments for long COVID

The company reported a quarterly revenue of $33.71 billion and a net profit of $1.06 billion in their latest earnings release

Medicare soon will start something it hasn't done in its 58-year history: Negotiate on drug prices. On Sept. 1, Medicare will target the first 10 drugs for price negotiations.

The ever-transforming pharmaceuticals sector is ready to seize the opportunity to address the growing demand for healthcare across the globe. Therefore, adding these three quality pharma stocks, Johnson & Johnson (JNJ), Eli Lilly and Company (LLY), and Dr. Reddy's Laboratories (RDY), to your portfolio could prove to be beneficial. Read…